Events & Webinars
Podcasts
Resources
Learning Zone
Products
Service Optimization & Formularies
Cardiovascular
Women's Health
Nephrology
Oncology
Respiratory
Bayer for Professionals
Your Resource Portal
Register | Log In
PP-PF-OTH-GB-0055 | February 2024
Explore Bayer Products
Nephrology & Cardiology Products
Xarelto®
Protect what matters most for your eligible cardiovascular patients
Xarelto Prescribing Information
PP-XAR-GB-3601, February 2024
Kerendia®▼ (finerenone)
Product Page
Kerendia (finerenone) UK Prescribing Information
PP-KER-GB-0468, March 2024
Oncology Products
Stivarga® (regorafenib)
In mCRC
Stivarga Prescribing Information
PP-STI-GB-0204, February 2024
Nexavar® (sorafenib) & Stivarga® (regorafenib)
In HCC
Nexavar Prescribing Information
Stivarga Prescribing Information
PP-NEX-GB-0211, February 2024
Xofigo®▼ (radium-223 dichloride)
In mCRPC
Xofigo Prescribing Information
PP-XOF-GB-0460, February 2024
NUBEQA®▼ (darolutamide)
In nmCRPC and mHSPC
NUBEQA GB Prescribing Information
NUBEQA NI Prescribing Information
PP-NUB-GB-1317, February 2024
Women's Health Products
Qlaira® (Estradiol valerate/dienogest)
Qlaira Prescribing information
PP-PF-WHC-IUS-GB-0025, February 2024
Jaydess® ▼ (13.5mg levonorgestrel)
Jaydess Prescribing Information
PP-PF-WHC-IUS-GB-0026 February 2024
Kyleena® 19.5mg levonorgestrel
Kyleena® Prescribing Information
PP-PF-WHC-IUS-GB-0018, February 2024